Liver Disorder due to PD-1 Inhibitors in the Clinical Setting

(1) St. Luke's International Hospital,Tokyo,Japan



This item was part of the Cirrhosis and liver cancer session at UEG Week 2019

This item can be cited as: United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019